Why Is United Therapeutics (UTHR) Down 0.3% Since Last Earnings Report?Zacks Investment Research • 03/26/21
United Therapeutics Corporation To Present At The 10th Annual J.P. Morgan Napa Valley ForumPRNewsWire • 03/24/21
United Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare ConferencePRNewsWire • 03/09/21
United Therapeutics Corporation To Present At The 41st Annual Cowen Health Care ConferencePRNewsWire • 02/24/21
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/24/21
United Therapeutics Corporation Reports Fourth Quarter And Full Year 2020 Financial ResultsPRNewsWire • 02/24/21
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Q4 ReleaseZacks Investment Research • 02/17/21
United Therapeutics Corporation To Report Fourth Quarter And Full Year 2020 Financial Results Before The Market Opens On Wednesday, February 24, 2021PRNewsWire • 02/17/21
United Therapeutics Announces BREEZE Study of Investigational Tyvaso DPI™ Meets Primary ObjectivePRNewsWire • 01/28/21
United Therapeutics Announces New England Journal of Medicine Publication of the INCREASE Study Evaluating Tyvaso® in Pulmonary Hypertension Associated with Interstitial Lung DiseasePRNewsWire • 01/13/21
United Therapeutics Corporation To Present At The 39th Annual J.P. Morgan Healthcare ConferencePRNewsWire • 01/04/21
United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary FibrosisPRNewsWire • 12/09/20
United Therapeutics (UTHR) Up 2.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/27/20
United Therapeutics Corporation To Present At The Jefferies Virtual London Healthcare ConferencePRNewsWire • 11/10/20
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/28/20
United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 MeetingPRNewsWire • 10/22/20